Roivant Sciences Ltd.ROIVNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank83
3Y CAGR+0.1%
5Y CAGR+2.4%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+0.1%/yr
Annual compound
5Y CAGR
+2.4%/yr
Consistent
Percentile
P83
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $1.23B | +19.0% |
| 2024 | $1.03B | +123.1% |
| 2023 | $-4.47B | -465.0% |
| 2022 | $1.22B | -12.5% |
| 2021 | $1.40B | +27.9% |
| 2020 | $1.09B | +82.4% |
| 2019 | $598.98M | - |